This inventor holds 8 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Sanyo Electric Co., Ltd., Japan Tobacco Inc.. Active years: 1993-2011.
Location History:
- Osaka-fu, JP (1997)
- Osaka, JP (1996 - 1998)
- Hirakata, JP (1993 - 2000)
- Takatsuki, JP (2011)
Company Filing History:
Years Active: 1993-2011
Title: Masahiro Sakata: Innovator in Pain Management
Introduction
Masahiro Sakata is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target pain management. With a total of 8 patents to his name, Sakata's work has the potential to impact the treatment of various pain-related conditions.
Latest Patents
Sakata's latest patents include innovative compounds such as condensed benzamide compounds and inhibitors of vanilloid receptor subtype 1 (VR1) activity. These compounds are designed to provide an excellent inhibitory effect on VR1 activity, which is crucial in treating diseases associated with pain, including acute pain, chronic pain, neuropathic pain, rheumatoid arthritis pain, and neuralgia. Another notable patent involves 3,4-dihydrobenzoxazine compounds, which also target VR1 activity and are effective in treating pain-related diseases.
Career Highlights
Throughout his career, Masahiro Sakata has worked with notable companies, including Sanyo Electric Co., Ltd. and Japan Tobacco Inc. His experience in these organizations has contributed to his expertise in pharmaceutical innovation and development.
Collaborations
Sakata has collaborated with esteemed colleagues such as Goro Hamagishi and Shunichi Kishimoto. These partnerships have likely enhanced his research and development efforts in the field of pain management.
Conclusion
Masahiro Sakata's contributions to the pharmaceutical industry, particularly in pain management, highlight his innovative spirit and dedication to improving healthcare. His patents reflect a commitment to developing effective treatments for pain-related conditions, making him a significant figure in the field.